Therapy of moderate cognitive impairment and asthenia in patients with cerebrovascular pathology: results of a prospective observational study

202215 citationsJournal Article

Authors

G. I. Shvartsman · North-Western State Medical University named after I.I. Mechnikov

А. А. Скоромец · First Pavlov State Medical University of St. Petersburg

С. А. Живолупов · S. M. Kirov Military Medical Academy

О. В. Курушина · Volgograd State Medical University

S. M. Karpov · Stavropol State Medical University

Natalia B. Baranova · Yaroslavl State Medical Academy

M V Nesterova

Abstract

The nootropic medication Prospekta is effective and safe in treatment of MCI in patients with asthenia with CVD, and improves cognitive function in patients with asthenia with CVD, both in monotherapy and in combination with other nootropic agents.

Topics & Keywords

Neurological Disorders and Treatments Medicinal Plants and Bioactive Compounds Chemical and Physical Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: S S Korsakov Journal of Neurology and Psychiatry

Volume 122, Issue 8, pp. 88-88

DOI: 10.17116/jnevro202212208188

Field-Weighted Citation Impact: 1.26